Misdiagnosing Pediatric Brain Tumors

October 26, 2018

New molecular tests have revealed notable differences between cancers once thought to be the same.

Long established practices of diagnosing brain cancers in children are flawed, according to a new study. Due to this, children with uncommon tumors have been receiving incorrect diagnoses and occasionally incorrect treatments. New tests which can observe tumor cells’ genetic profiles revealed this startling possibility.

As a result, Dr. Jim Olson, lead scientist of this study and the Fred Hutchinson Cancer Research Center recommends fellow childhood brain cancer specialists to use these newly developed tests.

This test, known as DNA methylation profiling, is necessary according to Olson, as “Tumors often look identical when viewed under a microscope, however, they can have very different biology and may require different forms of treatment.”

Read More

Child Cancer Support Blog

Leave a Comment

Your email address will not be published. Required fields are marked *

Previous reading
Novel Study discovers protein inhibitors associated with DIPG, a distressing form of childhood brain cancer
Next reading
Researchers find a ‘critical need’ for whole genome sequencing of young cancer patients